APN Health

APN Health is a private digital health/diagnostics company targeting the high-cost cardiac electrophysiology (EP) mapping market with its Navik 3D software system. Its core innovation is a hardware-agnostic platform that generates 3D cardiac maps using existing hospital fluoroscopy systems, dramatically reducing the capital equipment cost (from $250K-$800K to near-zero) and per-procedure expense compared to incumbent magnetic or impedance-based 3D mapping systems. With FDA clearance since 2016, over 150 procedures performed, and a strong IP portfolio, the company is positioned to expand access to catheter ablation by improving procedural economics for hospitals.

Proprietary software algorithms that create 3D cardiac maps and enable catheter tracking using standard 2D fluoroscopy images, independent of specific hardware.

APN Health competes against established giants in the cardiac EP mapping space, primarily Johnson & Johnson (Biosense Webster's CARTO system) and Abbott (EnSite Precision system), which rely on proprietary, expensive capital hardware. Its primary competitive advantage is a radically lower cost structure and hardware flexibility, though it must compete against these deeply entrenched technologies with extensive clinical validation and global sales forces.